Download Leukaemia Section t(16;21)(p11;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

X-inactivation wikipedia , lookup

Transcriptional regulation wikipedia , lookup

List of types of proteins wikipedia , lookup

RNA-Seq wikipedia , lookup

Transcript
Atlas of Genetics and Cytogenetics
in Oncology and Haematology
OPEN ACCESS JOURNAL AT INIST-CNRS
Leukaemia Section
Short Communication
t(16;21)(p11;q22)
Christine Pérot
Laboratoire de Cytogenetique, Hopital Saint-Antoine, Paris, France
Published in Atlas Database: February 1998
Online updated version: http://AtlasGeneticsOncology.org/Anomalies/t1621.html
DOI: 10.4267/2042/37420
This work is licensed under a Creative Commons Attribution-Non-commercial-No Derivative Works 2.0 France Licence.
© 1998 Atlas of Genetics and Cytogenetics in Oncology and Haematology
ERG
Clinics and pathology
Location: 21q22
Disease
Results of the chromosomal
anomaly
De novo ANLL; (one case of blast crisis CML).
Phenotype / cell stem origin
Mainly M2 or M4, but also M1, M5a, M5b, or M7
ANLL; may be preceded by MDS.
Epidemiology
About 30 reported cases, mainly found in young adults;
children cases are described; median age is about 30
yrs; balanced sex ratio.
Clinics
Blood data: anemia, thrombocytopenia, mild
hyperleucocytosis; with high monocytic cell count at
times.
Cytology
Myelocytic and monocytoid features are often present;
eosinophils in the bone marrow are sometimes
abnormal and/or elevated; erythrophagocytosis may be
found.
Prognosis
Seems poor: complete remission may not be achieved;
there is high incidence of relapse within a year and a
median of survival is about 22 months (cases herein
reviewed).
Hybrid gene
Description
5' FUS - 3' ERG
Fusion protein
Description
N-term FUS RNA binding domain fused to the C-term
DNA binding ETS domain of ERG.
Oncogenesis
Seems to act as a transcriptional activator.
References
Mecucci C, Bosly A, Michaux JL, Broeckaert-Van Orshoven A,
Van den Berghe H. Acute nonlymphoblastic leukemia with
bone marrow eosinophilia and structural anomaly of
chromosome 16. Cancer Genet Cytogenet 1985;17:359-63.
Morgan R, Riske CB, Meloni A, Ries CA, Johnson CH, Lemons
RS, Sandberg AA. t(16;21)(p11.2;q22): a recurrent primary
rearrangement in ANLL. Cancer Genet Cytogenet 1991;53:8390.
Hiyoshi M, Koh KR, Yamane T, Tatsumi N. Acute nonlymphoblastic leukaemia with t(16;21): case report with a
review of the literature. Clin Lab Haematol 1995;17:243-6.
Cytogenetics
Additional anomalies
Kong XT, Ida K, Ichikawa H, Shimizu K, Ohki M, Maseki N,
Kaneko Y, Sako M, Kobayashi Y, Tojou A, Miura I, Kakuda H,
Funabiki T, Horibe K, Hamaguchi H, Akiyama Y, Bessho F,
Yanagisawa M, Hayashi Y. Consistent detection of TLS/FUSERG chimeric transcripts in acute myeloid leukemia with
t(16;21)(p11;q22) and identification of a novel transcript. Blood
1997;90:1192-9.
Rarely found solely; most often associated with various
numerical or structural abnormalities; trisomy 10 was
found in 4 of 17 cases.
Genes involved and Proteins
This article should be referenced as such:
FUS
Pérot C. t(16;21)(p11;q22). Atlas Genet Cytogenet Oncol
Haematol.1998;2(2):62.
Location: 16p11
Atlas Genet Cytogenet Oncol Haematol. 1998;2(2)
62
Related documents
Leukaemia Section t(3;5)(q25;q34)  Atlas of Genetics and Cytogenetics
Leukaemia Section t(3;5)(q25;q34) Atlas of Genetics and Cytogenetics
Leukaemia Section t(1;21)(p36;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;21)(p36;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(2;21)(p11;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(2;21)(p11;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Genes Section DDX10 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 10) Atlas of Genetics and Cytogenetics
Genes Section DDX10 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 10) Atlas of Genetics and Cytogenetics
Leukaemia Section t(18;21)(q21;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(18;21)(q21;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section dic(17;20)(p11.2;q11.2) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section dic(17;20)(p11.2;q11.2) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section LCP1 (lymphocyte cytosolic protein1) Atlas of Genetics and Cytogenetics
Gene Section LCP1 (lymphocyte cytosolic protein1) Atlas of Genetics and Cytogenetics
Leukaemia Section t(1;21)(p35;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;21)(p35;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;21)(q21;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;21)(q21;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;21)(q26;q22) in treatment related leukemia Atlas of Genetics and Cytogenetics
Leukaemia Section t(3;21)(q26;q22) in treatment related leukemia Atlas of Genetics and Cytogenetics
Leukaemia Section t(12;21)(p12;q22)  Atlas of Genetics and Cytogenetics
Leukaemia Section t(12;21)(p12;q22) Atlas of Genetics and Cytogenetics
Leukaemia Section t(8;11)(p11;p15) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(8;11)(p11;p15) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section ABI1 (Abl-Interactor 1) Atlas of Genetics and Cytogenetics
Gene Section ABI1 (Abl-Interactor 1) Atlas of Genetics and Cytogenetics
Leukaemia Section t(3;4)(q27;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;4)(q27;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(X;21)(q26;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(X;21)(q26;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(12;20)(q15;q11.2) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(12;20)(q15;q11.2) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(12;22)(p13;q11-12) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(12;22)(p13;q11-12) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(11;15)(q23;q14) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(11;15)(q23;q14) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(X;7)(q22;q34) IRS4/TCRB  Atlas of Genetics and Cytogenetics
Leukaemia Section t(X;7)(q22;q34) IRS4/TCRB Atlas of Genetics and Cytogenetics
Leukaemia Section t(5;17)(q33;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(5;17)(q33;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section CRTC1 (CREB regulated transcription coactivator 1) Atlas of Genetics and Cytogenetics
Gene Section CRTC1 (CREB regulated transcription coactivator 1) Atlas of Genetics and Cytogenetics
Leukaemia Section t(7;14)(q22;q11) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(7;14)(q22;q11) Atlas of Genetics and Cytogenetics in Oncology and Haematology